Understanding how cellular recycling centers function differently across brain cell types could revolutionize approaches to neurodegeneration treatment. Most lysosomal storage diseases affect the brain, yet scientists have lacked detailed maps of how these critical organelles vary between neurons, astrocytes, and other brain cells.
Researchers created the first comprehensive protein atlas of lysosomes across four major brain cell types in mice, revealing dozens of previously unknown lysosomal proteins and significant compositional differences between cell types. The team identified SLC45A1 as a neuron-specific lysosomal protein whose mutations cause a rare neurological disease. When SLC45A1 is lost, lysosomes accumulate excess sugar, their pH becomes too alkaline, and iron homeostasis breaks down, ultimately damaging mitochondria. The protein functions as a sugar transporter and helps stabilize V-ATPase complexes that maintain proper lysosomal acidity.
This discovery reclassifies SLC45A1-associated neurological disease as a lysosomal storage disorder, potentially opening new therapeutic avenues. The finding exemplifies how cell-type-specific lysosomal functions contribute to neurodegeneration - a concept that could explain why certain brain regions are selectively vulnerable in diseases like Parkinson's and Alzheimer's. The comprehensive atlas provides a foundation for understanding how lysosomal dysfunction manifests differently across brain cell populations. While the work was conducted in mice, the evolutionary conservation of lysosomal machinery suggests these insights will translate to human neurodegenerative diseases, though clinical validation remains essential.